J. Kincaid

发表

Novel bis-Tetrahydrofuranylurethane-Containing Nonpeptidic Protease Inhibitor (PI) UIC-94017 (TMC114) with Potent Activity against Multi-PI-Resistant Human Immunodeficiency Virus In Vitro

Irene T. Weber, Robert W. Harrison, Patra Volarath, 2003, Antimicrobial Agents and Chemotherapy.

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

A. Marx, S. Muley, R. Conwit, 2019, The Lancet Neurology.

Structure-activity relationships of a series of pyrrolo[3,2-d]pyrimidine derivatives and related compounds as neuropeptide Y5 receptor antagonists.

N. Chen, Z. Chen, V. Santora, 2000, Journal of medicinal chemistry.

Synthesis and structure-activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitors.

A. Malikzay, P. Kussie, M. C. Tuma, 2005, Bioorganic & medicinal chemistry letters.

2-Amino-5-arylbenzoxazole derivatives as potent inhibitors of fatty acid amide hydrolase (FAAH)

Fabien Vincent, D. Emerling, M. Duncton, 2012 .

Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment

G. Ardissino, H. Haller, J. Walle, 2016, Journal of Nephrology.

Nonpeptidal P2 ligands for HIV protease inhibitors: structure-based design, synthesis, and biological evaluation.

D. Walters, P. Darke, W. Schleif, 1996, Journal of medicinal chemistry.

Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere.

D. Walters, A. Ghosh, K. A. Hussain, 1998, Bioorganic & medicinal chemistry letters.

Nonpeptidal P2 Ligands for HIV Protease Inhibitors: Structure‐Based Design, Synthesis, and Biological Evaluation.

Arun K. Ghosh, D. Walters, P. Darke, 1996 .

Eculizumab improves fatigue in refractory generalized myasthenia gravis

K. Patra, P. van Damme, M. Benatar, 2019, Quality of Life Research.

Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study

N. Sheerin, C. Licht, E. Rondeau, 2018, Clinical kidney journal.

Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis

G. Remuzzi, T. Feldkamp, N. Sheerin, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

Potent HIV protease inhibitors incorporating high-affinity P2-ligands and (R)-(hydroxyethylamino)sulfonamide isostere.

D. Walters, A. Ghosh, K. A. Hussain, 1998, Bioorganic & medicinal chemistry letters.

Carbazole-containing sulfonamides and sulfamides: Discovery of cryptochrome modulators as antidiabetic agents.

K. McCluskie, Paul S. Humphries, J. Kincaid, 2016, Bioorganic & medicinal chemistry letters.

Preparation of aryloxetanes and arylazetidines by use of an alkyl-aryl suzuki coupling.

M. Cox, M. Duncton, M. A. Estiarte, 2008, Organic letters.

Dibutyl 2-(trifluoromethyl)cyclopropylboronate as a useful (trifluoromethyl)cyclopropyl donor: application to antagonists of TRPV1

M. Duncton, N. Orike, J. Kincaid, 2010 .

Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in mice.

D. Donnelly-roberts, S. Arneric, J. Sullivan, 1998, Bioorganic & medicinal chemistry letters.

The effects of HCV infection and management on health‐related quality of life

Z. Younossi, J. Kallman, J. Kincaid, 2007, Hepatology.

Carbazole-containing amides and ureas: Discovery of cryptochrome modulators as antihyperglycemic agents.

K. McCluskie, Paul S. Humphries, J. Kincaid, 2017, Bioorganic & medicinal chemistry letters.

Thymic carcinoid with cutaneous hyperpigmentation.

E. Sunderrajan, J. Kincaid, T. Lieske, 1985, Archives of internal medicine.

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

P. van Damme, M. Benatar, F. Piehl, 2019, Journal of the Neurological Sciences.

MP393LONG-TERM SAFETY AND EFFECTIVENESS OF ECULIZUMAB FOR PATIENTS WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME: OUTCOMES FROM A PROSPECTIVE OBSERVATIONAL CLINICAL TRIAL

L. Pape, C. Licht, L. Greenbaum, 2017 .

BILATERAL RETINAL ARTERITIS WITH MULTIPLE ANEURYSMAL DILATATIONS

H. Schatz, J. Kincaid, 1983, Retina.

‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

P. van Damme, M. Benatar, F. Piehl, 2020, Journal of Neurology.

Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides.

N. Chen, J. Treanor, P. Chakrabarti, 2005, Journal of medicinal chemistry.

Identification of orally-bioavailable antagonists of the TRPV4 ion-channel.

J. Defalco, Qingling Zhang, Amy Gustafson, 2015, Bioorganic & medicinal chemistry letters.

A Convenient Enzymatic Route to Optically Active 1-Aminoindan-2-ol: Versatile Ligands for HIV-1 Protease Inhibitors and Asymmetric Syntheses

Arun K. Ghosh, J. Kincaid, Michael G. Haske, 1997, Synthesis.

Safety and Efficacy of Eculizumab in Adult aHUS Patients, With or Without Renal Transplant.: Abstract# B940

C. Bedrosian, C. Legendre, F. Fakhouri, 2014 .

Immunodeficiency Virus In Vitro against Multi-PI-Resistant Human UIC-94017 ( TMC 114 ) with Potent Activity Nonpeptidic Protease Inhibitor ( PI )-Tetrahydrofuranylurethane-Containing bis Novel

Irene T. Weber, Robert W. Harrison, Patra Volarath, 2003 .

Interpenetrating polymer networks of photocrosslinkable cellulose derivatives

M. Kamath, J. Kincaid, B. Mandal, 1996 .

Preparation of aryloxetanes and arylazetidines by use of an alkyl-aryl suzuki coupling.

M. Cox, M. Duncton, D. J. R. O'mahony, 2008, Organic letters.

Discovery of potent, non-carbonyl inhibitors of fatty acid amide hydrolase (FAAH)

J. Defalco, D. Emerling, M. Duncton, 2012 .